Showing results (11-20 of 23) with videos related to
Sort By:
Pageof 3
The American Review of Respiratory Disease|September 1, 1989
The epidemiology of pulmonary function and COPD mortality in the multiple risk factor intervention trialL H Kuller, J K Ockene, M Townsend, et al.Statistics in Medicine|October 15, 1994
Considerations in choice of a clinical endpoint for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)J D Neaton, D N Wentworth, F Rhame, et al.Preventive Medicine|September 1, 1991
Cigarette smoking and mortality. MRFIT Research GroupL H Kuller, J K Ockene, E Meilahn, et al.JAMA|February 20, 1987
Serum cholesterol levels and cancer mortality in 361,662 men screened for the Multiple Risk Factor Intervention TrialR W Sherwin, D N Wentworth, J A Cutler, et al.Circulation|March 1, 1988
Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention TrialG H Rutan, L H Kuller, J D Neaton, et al.Lancet (London, England)|February 8, 1992
Toxicity of clindamycin as prophylaxis for AIDS-associated toxoplasmic encephalitis. Community Programs for Clinical Research on AIDSM A Jacobson, C L Besch, C Child, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 10, 1998
Acyclovir use and survival among human immunodeficiency virus-infected patients with CD4 cell counts of < 500/mm3. The Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA)R A Torres, J D Neaton, D N Wentworth, et al.Antiviral Therapy|June 10, 2000
Frequency of antiretroviral drug resistance mutations in HIV-1 strains from patients failing triple drug regimens. The Terry Beirn Community Programs for Clinical Research on AIDSM A Winters, J D Baxter, D L Mayers, et al.The Journal of Infectious Diseases|February 1, 1994
Primary prophylaxis with pyrimethamine for toxoplasmic encephalitis in patients with advanced human immunodeficiency virus disease: results of a randomized trial. Terry Beirn Community Programs for Clinical Research on AIDSM A Jacobson, C L Besch, C Child, et al.AIDS (London, England)|May 11, 2002
Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapyJohn D Baxter, Thomas C Merigan, Deborah N Wentworth, et al.Pageof 3